Pfizer Slams Out-Of-State Claims Over Robitussin Label
Pfizer Inc. renewed its bid to dismiss nationwide class claims from a suit alleging it overcharged consumers for its "Maximum Strength" Robitussin compared to its regular version, telling an Illinois federal...To view the full article, register now.
Already a subscriber? Click here to view full article